WallStSmart

Medtronic PLC (MDT)vsKoninklijke Philips NV ADR (PHG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 99% more annual revenue ($35.48B vs $17.83B). MDT leads profitability with a 13.0% profit margin vs 5.0%. PHG appears more attractively valued with a PEG of 0.36. MDT earns a higher WallStSmart Score of 56/100 (C).

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0

PHG

Hold

49

out of 100

Grade: D+

Growth: 5.3Profit: 5.0Value: 7.3Quality: 5.3
Piotroski: 6/9Altman Z: 1.47
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTSignificantly Overvalued (-254.0%)

Margin of Safety

-254.0%

Fair Value

$24.34

Current Price

$86.16

$61.82 premium

UndervaluedFair: $24.34Overvalued
PHGSignificantly Overvalued (-340.5%)

Margin of Safety

-340.5%

Fair Value

$7.28

Current Price

$26.25

$18.97 premium

UndervaluedFair: $7.28Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$113.55B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

PHG4 strengths · Avg: 9.0/10
PEG RatioValuation
0.3610/10

Growing faster than its price suggests

Revenue GrowthGrowth
110.0%10/10

Revenue surging 110.0% year-over-year

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$1.31B8/10

Generating 1.3B in free cash flow

Areas to Watch

MDT2 concerns · Avg: 3.0/10
PEG RatioValuation
1.554/10

Expensive relative to growth rate

EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

PHG4 concerns · Avg: 3.0/10
P/E RatioValuation
26.4x4/10

Moderate valuation

Return on EquityProfitability
7.8%3/10

ROE of 7.8% — below average capital efficiency

Profit MarginProfitability
5.0%3/10

5.0% margin — thin

EPS GrowthGrowth
-50.0%2/10

Earnings declined 50.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bull Case : PHG

The strongest argument for PHG centers on PEG Ratio, Revenue Growth, Price/Book. Revenue growth of 110.0% demonstrates continued momentum. PEG of 0.36 suggests the stock is reasonably priced for its growth.

Bear Case : MDT

The primary concerns for MDT are PEG Ratio, EPS Growth.

Bear Case : PHG

The primary concerns for PHG are P/E Ratio, Return on Equity, Profit Margin.

Key Dynamics to Monitor

MDT profiles as a value stock while PHG is a hypergrowth play — different risk/reward profiles.

PHG carries more volatility with a beta of 0.94 — expect wider price swings.

PHG is growing revenue faster at 110.0% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (56/100 vs 49/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Koninklijke Philips NV ADR

HEALTHCARE · MEDICAL DEVICES · USA

Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally. The company is headquartered in Amsterdam, the Netherlands.

Want to dig deeper into these stocks?